Event chart NOVAVAX, INC. |
|
|
Upcoming events on NOVAVAX, INC. |
|
02/27/23 | | FY 2022 Earnings Release (Projected) |
05/08/23 | | Q1 2023 Earnings Release (Projected) |
08/03/23 | | Interim 2023 Earnings Release (Projected) |
11/02/23 | | Q3 2023 Earnings Release (Projected) |
|
Past events on NOVAVAX, INC. |
|
01/09/23 | 08:15pm | | JP Morgan Healthcare Conference |
12/07/22 | 09:10am | | BofA Securities Virtual Biotech SMID Cap Conference |
11/16/22 | 03:35am | | Jefferies London Healthcare Conference |
11/08/22 | 04:30pm | | Q3 2022 Earnings Call |
11/08/22 | | Q3 2022 Earnings Release |
10/22/22 | 12:15pm | | IDWeek Conference - Shinde, V |
10/22/22 | 10:15am | | IDWeek Conference |
10/20/22 | 01:45pm | | IDWeek Conference - Áñez, G |
10/13/22 | 08:30am | | World Vaccine Congress |
10/12/22 | 02:30am | | World Vaccine Congress |
|
Past dividends on NOVAVAX, INC. |
|
- No events available -
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 31,2 28,7 8,5% | 34,3 35,3 -2,8% | 18,7 11,8 58% | 476 398 19% | 1 146 1 263 -9,3% | 1 947 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -154 -149 -3,8% | -166 -158 -4,6% |
|
|
| -455 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -172 -168 -2,1% | -174 -172 -1,3% | -130 -121 -7,5% | -417 -393 -6,0% | -1 687 -979 -72% | -480 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -184 -180 -2,3% | -185 -182 -1,4% | -133 -128 -3,9% | -418 -383 -9,3% | -1 715 -1 007 -70% | -548 |
Net income M $ |
Released Forecast Spread | -184 -180 -2,0% | -185 -182 -1,4% | -133 -130 -2,4% | -418 -383 -9,3% | -1 744 -1 021 -71% | -535 |
EPS $ |
Released Forecast Spread | -12,6 -12,4 -1,5% | -10,0 -10,2 2,4% | -5,51 -5,42 -1,6% | -7,27 -6,58 -11% | -23,4 -13,7 -71% | -7,12 | Announcement Date | 03/14/2018 | 03/18/2019 | 03/11/2020 | 03/01/2021 | 02/28/2022 | - |
|
|
Fiscal Period : December | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
Sales M $ |
Released Forecast Spread | 157 231 -32% | 280 202 38% | 447 234 91% | 298 388 -23% | 179 347 -49% | 222 332 -33% | 704 845 -17% | 186 1 017 -82% | 735 555 32% | 365 | 368 | 365 | 402 | 481 |
Operating income (EBITDA) M $ |
Released Forecast Spread |
|
|
|
|
|
|
|
| -119 310 -138% |
|
|
|
|
|
Operating profit (EBIT) M $ |
Released Forecast Spread | -194 113 -272% | -183 -159 -15% | -209 -256 19% | -346 -269 -29% | -307 -275 -12% | -825 -114 -627% | 209 247 -15% | -483 486 -199% | -127 139 -192% | -93,3 | -122 | -88,9 | -53,5 | 53,3 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -197 88,1 -324% | -178 -142 -25% | -220 -265 17% | -349 -271 -29% | -316 -276 -15% | -830 -118 -605% | 206 242 -15% | -509 495 -203% | -166 93,2 -278% | -91,6 | -124 | -91,1 | -55,7 | 51,1 |
Net income M $ |
Released Forecast Spread | -197 109 -280% | -178 -142 -25% | -223 -256 13% | -352 -271 -30% | -322 -282 -14% | -846 -124 -584% | 203 213 -4,7% | -510 449 -214% | -169 132 -227% | -80,4 | -118 | -86,5 | -52,9 | 48,5 |
EPS $ |
Released Forecast Spread | -3,21 1,73 -285% | -2,70 -2,24 -21% | -3,05 -3,60 15% | -4,75 -3,25 -46% | -4,31 -3,73 -16% | -11,2 -1,80 -520% | 2,56 2,65 -3,5% | -6,53 5,50 -219% | -2,15 1,64 -231% | -1,14 | -1,71 | -1,63 | -1,24 | -0,72 | Announcement Date | 11/09/2020 | 03/01/2021 | 05/10/2021 | 08/05/2021 | 11/04/2021 | 02/28/2022 | 05/09/2022 | 08/08/2022 | 11/08/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for NOVAVAX, INC. |
|
|
|
Past sector events for NOVAVAX, INC. |
|
|
|
|
|
|
Novavax cuts full-year revenue forecast |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|